Int. J. Mol. Sci., 2023 · DOI: 10.3390/ijms241814349 · Published: September 20, 2023
Spinal cord injuries (SCIs) can lead to significant neurological deficits and lifelong disability, impacting individuals and families physically, psychologically, and economically. Current treatments have limitations in restoring function, creating a need for innovative therapeutic approaches. Stem cell therapy has emerged as a promising strategy to promote the regeneration and repair of damaged neural tissue following SCIs. Different stem cell types, like embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), mesenchymal stem cells (MSCs), and neural stem/progenitor cells (NSPCs), hold potential for SCI treatment. This article highlights the importance of collaboration among scientists, clinicians, bioengineers, industry, and patients to overcome challenges and fully realize stem cell therapy's potential for SCI patients. By fostering collaborations, we can develop groundbreaking therapies to improve the lives of those affected by SCIs.
Stem cell therapies can potentially revolutionize the treatment of SCIs by promoting the regeneration and repair of damaged neural tissue, offering hope for functional recovery.
Exploring different stem cell types and incorporating advancements in gene editing and biomaterials can lead to personalized therapeutic strategies tailored to individual patient needs.
Fostering collaboration among scientists, clinicians, engineers, and industry is crucial for accelerating progress in stem cell therapies and ensuring the development of effective and accessible treatments.